Evidence map›Paper›PMID 30838153›Full record

ArticleCase reports in urology2019

Pulmonary Embolism following Percutaneous Nephrolithotomy: An Uncommon and Life-Threatening Complication.

Spyridon Paparidis, Antonios Katsimantas, Dimitrios Oikonomidis, Nikolaos Ferakis

Open access · goldAbstract readCase Reports
In one paragraph

Article in Case reports in urology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. A case of fatal embolization during laser lithotripsy.International journal of legal medicine · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Spyridon PaparidisUrology Department, Korgialenio-Benakio Hellenic Red Cross Hospital, Athanasaki 1, 11526 Athens, Greece.ORCID 0000-0002-5180-7037
Antonios KatsimantasUrology Department, Korgialenio-Benakio Hellenic Red Cross Hospital, Athanasaki 1, 11526 Athens, Greece.ORCID 0000-0003-4695-7724
Dimitrios OikonomidisSecond Cardiology Department, Korgialenio-Benakio Hellenic Red Cross Hospital, Athanasaki 1, 11526 Athens, Greece.
Nikolaos FerakisUrology Department, Korgialenio-Benakio Hellenic Red Cross Hospital, Athanasaki 1, 11526 Athens, Greece.ORCID 0000-0002-5730-7308
Hellenic Red Cross · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

High risk pulmonary embolism is a rare and life-threatening complication following percutaneous nephrolithotomy. We report the case of a previously healthy, 44-year-old male, who developed acute pulmonary embolism following right percutaneous nephrolithotomy. On the 1st postoperative day, the patient presented with hemodynamic instability, acute respiratory distress, hypoxia, and loss of consciousness. He was urgently intubated and placed on mechanical ventilation. Clinical findings set the suspicion of pulmonary embolism with shock. Chest computed tomography scan confirmed the diagnosis. The patient underwent urgent thrombolysis in the cardiac care unit. On the 2nd postoperative day, the patient was admitted to the intensive care unit due to hemodynamic instability and fever. The postoperative course was complicated by right renal bleeding on the 3rd postoperative day, which was managed through angiography and angioembolization of the lower segmental right renal artery, followed by recurrent respiratory and urinary tract infections. The patient was transferred back to the urology department on the 66th postoperative day and was discharged seven days later.

Identifiers

PMID30838153
PMCPMC6374826
OpenAlexW2913184397

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.